創科(00669.HK):疫情下擴銷售團隊搶市佔 料增長勢頭持續
創科實業(00669.HK)行政總裁Joseph Galli出席網上業績發布會時表示,疫情下留意到部分競爭對手感到畏懼,並預計銷售跌幅達雙位數,但公司在疫情之初已採取了不同的策略,積極投資於生產、庫存並提升產能,藉機捕捉市場份額,而疫情期間公司亦積極擴張銷售團隊,向客戶推銷產品,帶動上半年銷售大幅跑贏同業。
他又強調上半年的銷售增長並非單次事件,認為勢頭將持續至下半年,而期內毛利率續提升至38%,反映除銷售增長外產品組合亦有改善。他指出疫情對所有人都有影響,亦未知要多長時間應對,但會繼續積極投資於可推動銷售的範疇,並開發新產品助用戶應對疫情,除工程承辦商外,旗下產品亦可助用家自行改裝家用健身室,或改裝作在家學習等,認為在疫情的新常態下最重要是做足抗疫措施,保障員工及其家人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.